Share this story:

CBD Global Sciences Expands Distribution Partnership with New Age, Inc.



CBD Global Sciences Inc.

Denver, Colorado – TheNewswire - September 16, 2020 – CBD Global Sciences Inc. (CSE:CBDN) (OTC:CBDNF) (Frankfurt:GS3) (CNSX:CBDN.CN), (“CBD Global” or the “Company”), is pleased to announce their distribution agreement with NewAge, Inc. (Nasdaq: NBEV).  The agreement expands our Aethics CBD brand and products into traditional retail, e-commerce, and other supply channels with a Colorado based healthy and organic products company which has a current presence in more than 60 countries.

 

With the launch of our Aethics CBD products into the NewAge distribution channels and the success of the demand for the products, Aethics is now being sold in 200+ locations and it continues to expand to additional stores on a weekly basis. New Age is focused on distributing the Aethics brand of products into their more than 5,000 stores throughout the Western United States.

 

“We are pleased to announce our partnership with NewAge, Inc. and their distribution capabilities” commented Brad Wyatt, President and CEO of CBD Global Sciences. “We look forward to working with and supporting NewAge in helping both companies expand their CBD product categories into new markets”.

 

ABOUT NEWAGE, INC.

NewAge, Inc. (Nasdaq: NBEV), is a Colorado-based organic and healthy company dedicated to inspiring and educating consumers to “Live Healthy.” We are the only omni-channel company with access to traditional retail, e-commerce, direct-to-consumer, and other channels across more than 60 countries worldwide, with a network of over 250,000 exclusive independent product consultants around the globe. NewAge, Inc. markets a portfolio of better-for-you products including the brands Tahitian Noni, TeMana, Nestea, Volvic, Illy Coffee, Evian, Bucha Live Kombucha, ‘Nhanced and others.  The company operates the website newage.com, noninewage.com, and a number of other individual brand websites.

 

ABOUT CBD GLOBAL SCIENCES INC.

CBD Global Sciences Inc., is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle which currently owns two product categories, branded under the name AETHICS (www.aethics.com) and CANNAOIL (www.cannaoilshop.com), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals and CBD hydration products.  CBD Global’s hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.

CBD Global Sciences, through its wholly owned subsidiary, Strasburg Pharms, grows and operates irrigated land in Colorado that grows hemp with only all-natural Colorado water, soil, sun and nutrients that is NEVER sprayed with pesticides or chemicals.  Our genetics are hand selected and maintained to present the best cannabinoid profile with extremely high CBD.  The extraction/processing facility, operated by CBD Global, is located approximately 40 minutes from the farm.

For further information, please contact Bruce Nurse, Investor Relations, (303) 919-2913, info@cbdglobalsciences.com.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to future developments and the business and operations of the Corporation after the CSE listing.  Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals.  Readers should not place undue reliance on forward-looking statements.  The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.